Select Bibliography

Filter by any of these (after searching):

Armer, Jane M

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 11 items

Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: Results of ACOSOG (American College Of Surgeons Oncology Group) Z1071 (Alliance) Substudy

Armer, Jane M. , Ballman, Karla V. , McCall, Linda , Armer, Nathan C. ... - - Support Care Cancer - 2019

Manuscript - Secondary - Primary - Breast - ACOSOG-Z1071

Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection

Armer, Jane M. , Ballman, Karla V. , McCall, Linda , Ostby, Pamela L. ... - - JAMA Surg - 2019

Manuscript - Secondary - Primary - Breast - ACOSOG-Z1071

Lymphedema results of Alliance Z1071 (American College of Surgeons Oncology Group [ACOSOG]): Self-reported symptoms and limb volume changes for breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection

Armer, Jane M. , Ballman, Karla , McCall, Linda , Suman, Vera ... - ILF - - 2018

Abstract - Secondary - Primary - Breast - ACOSOG-Z1071

Symptoms and limb changes for breast cancer survivors treated with neoadjuvant chemotherapy: Lymphedema results of ACOSOG Z1071 (Alliance)

Armer, Jane M. , Ballman, Karla , McCall, Linda , Suman, Vera ... - MASCC / ISOO - Supportive Cancer Care - 2017

Abstract - Secondary - Primary - Breast - ACOSOG-Z1071

Effects of a lymphedema prevention intervention on range of motion among women receiving axillary node dissection for breast cancer treatment (Alliance) CALGB 70305

Armer, Jane M , Liu, Heshan , Oliveri, Jill , Seisler, Drew , tbd ... - ASCO CSS - J Clin Oncol - 2018

Abstract - Secondary - Primary - Symptom Inter - CALGB-70305

Factors associated with lymphedema in patients/women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection on a prospective clinical trial (Alliance) ACOSOG Z1071

Boughey, Judy C. , Ballman, Karla , McCall, Linda , Kuerer, Henry ... - ASCO - J Clin Oncol - 2018

Abstract - Secondary - Primary - Breast - ACOSOG-Z1071

Nursing contributions in Community Clinical Oncology Research Programs.

Klinger, Kathy , Figueras, Cesar , Beney, Kathleen M , Armer, Jane M ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint - Other - Onc Nursing - No Study Assigned

Health-Related Quality of Life Outcomes for the LEAP Study - CALGB 70305 (Alliance): A Lymphedema Prevention Intervention Trial for Newly Diagnosed Breast Cancer Patients

Naughton, Michelle J. , Liu, Heshan , Seisler, Drew ... - - Cancer - 2021

Manuscript - Secondary - Primary - Health Outcomes - CALGB-70305

A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance)

Paskett, Electra D. , Le-Rademacher, Jennifer , Oliveri, Jill M. ... - - Cancer - 2021

Manuscript - Primary - Primary - Symptom Inter - CALGB-70305

The LEAP Study: Effects of a lymphedema prevention intervention on swelling, range of motion and quality of life (Alliance)

Paskett, Electra D. , Le-Rademacher, Jennifer , Oliveri, Jill ... - IPOS - Psycho-Oncol - 2018

Abstract - Primary - Primary - Symptom Inter - CALGB-70305

Effects of a lymphedema prevention intervention on range of motion among women receiving lymph node dissection for breast cancer treatment (Alliance) CALGB 70305.

Paskett, Electra D. , Liu, Heshan , Oliveri, Jill , Seisler, Drew K. ... - ILF - JCO - 2018

Abstract - Secondary - Primary - Symptom Inter - CALGB-70305